Cargando…
Strategies to Estimate Prevalence of SARS-CoV-2 Antibodies in a Texas Vulnerable Population: Results From Phase I of the Texas Coronavirus Antibody Response Survey
Introduction: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and immunity remains uncertain in populations. The state of Texas ranks 2nd in infection with over 2.71 million cases and has seen a disproportionate rate of death across the state. The Texas CARES project was funde...
Autores principales: | Valerio-Shewmaker, Melissa A., DeSantis, Stacia, Swartz, Michael, Yaseen, Ashraf, Gonzalez, Michael O., Kohl, Harold W. III, Kelder, Steven H., Messiah, Sarah E., Aguillard, Kimberly A., Breaux, Camille, Wu, Leqing, Shuford, Jennifer, Pont, Stephen, Lakey, David, Boerwinkle, Eric |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8712464/ https://www.ncbi.nlm.nih.gov/pubmed/34970525 http://dx.doi.org/10.3389/fpubh.2021.753487 |
Ejemplares similares
-
Antibody Duration After Infection From SARS-CoV-2 in the Texas Coronavirus Antibody Response Survey
por: Swartz, Michael D, et al.
Publicado: (2022) -
Methodology to estimate natural- and vaccine-induced antibodies to SARS-CoV-2 in a large geographic region
por: DeSantis, Stacia M., et al.
Publicado: (2022) -
SARS-CoV-2 Serostatus and COVID-19 Illness Characteristics by Variant Time Period in Non-Hospitalized Children and Adolescents
por: Messiah, Sarah E., et al.
Publicado: (2023) -
Clinical epidemiology of carbapenem-resistant Enterobacterales in the Greater Houston region of Texas: a 6-year trend and surveillance analysis
por: Tadese, Bekana K., et al.
Publicado: (2022) -
669. Changing Epidemiology of Murine Typhus in Texas
por: Shuford, Jennifer, et al.
Publicado: (2018)